Literature DB >> 2392509

Non-smokers show acute tolerance to subcutaneous nicotine.

M A Russell1, M J Jarvis, G Jones, C Feyerabend.   

Abstract

Plasma nicotine concentrations following subcutaneous (SC) injection were measured in six subjects who included three life-long nonsmokers. On average, a peak plasma level of 8.5 ng/ml (SD = 3.1) was reached 15 min after the mean dose of 13.25 micrograms/kg nicotine base. Subjective effects were reported by five subjects. The peak heart rate response (mean boost 11 beats per min at 10 min) preceded and was already declining by the time plasma nicotine concentrations peaked. Hysteresis plots showed clear evidence of acute nicotine tolerance in subjects who had never smoked, indicating that acute tolerance is not an acquired phenomenon. The acquisition by smokers of chronic tolerance to nicotine has not yet been systematically demonstrated. Reliable dose-response studies in smokers and nonsmokers are needed, and use of the SC route for this purpose is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2392509     DOI: 10.1007/bf02245744

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Cardiovascular and subjective effects of smoking before and after 24 h of abstinence from cigarettes.

Authors:  R J West; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Pharmacodynamic model of tolerance: application to nicotine.

Authors:  H C Porchet; N L Benowitz; L B Sheiner
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

3.  Effects of nicotine on finger tapping rate in non-smokers.

Authors:  R J West; M J Jarvis
Journal:  Pharmacol Biochem Behav       Date:  1986-10       Impact factor: 3.533

4.  Acute and chronic tolerance to nicotine measured by activity in rats.

Authors:  I P Stolerman; R Fink; M E Jarvik
Journal:  Psychopharmacologia       Date:  1973-06-29

5.  Assay of nicotine in biological materials: sources of contamination and their elimination.

Authors:  C Feyerabend; M A Russell
Journal:  J Pharm Pharmacol       Date:  1980-03       Impact factor: 3.765

Review 6.  Smoking, nicotine and human performance.

Authors:  K Wesnes; D M Warburton
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

7.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.

Authors:  N L Benowitz; P Jacob; R T Jones; J Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

8.  The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type.

Authors:  B Sahakian; G Jones; R Levy; J Gray; D Warburton
Journal:  Br J Psychiatry       Date:  1989-06       Impact factor: 9.319

  8 in total
  13 in total

1.  Nasal nicotine spray: a rapid nicotine delivery system.

Authors:  G Sutherland; M A Russell; J Stapleton; C Feyerabend; O Ferno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Persistent decrease in heart rate after smoking cessation: a 1-year follow-up study.

Authors:  A M Persico
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Sensitivity and tolerance to nicotine in smokers and nonsmokers.

Authors:  E D Srivastava; M A Russell; C Feyerabend; J G Masterson; J Rhodes
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

5.  Effects of nicotine and amphetamine on latent inhibition in human subjects.

Authors:  J C Thornton; S Dawe; C Lee; C Capstick; P J Corr; P Cotter; S Frangou; N S Gray; M A Russell; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

6.  A clinical pharmacological study of subcutaneous nicotine.

Authors:  J Le Houezec; P Jacob; N L Benowitz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study.

Authors:  J Foulds; K McSorley; J Sneddon; C Feyerabend; M J Jarvis; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

8.  A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia.

Authors:  Peggy Postma; Jeffrey A Gray; Tonmoy Sharma; Mark Geyer; Ravi Mehrotra; Mrigen Das; Elizabeth Zachariah; Melissa Hines; Steven C R Williams; Veena Kumari
Journal:  Psychopharmacology (Berl)       Date:  2006-02-02       Impact factor: 4.530

9.  Nicotine elimination and tolerance in non-dependent cigarette smokers.

Authors:  S Shiffman; M Zettler-Segal; J Kassel; J Paty; N L Benowitz; G O'Brien
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

Authors:  G M Jones; B J Sahakian; R Levy; D M Warburton; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.